Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter

被引:52
作者
Chen, NH
Ferrer, JV
Javitch, JA
Justice, JB
机构
[1] Emory Univ, Dept Chem, Atlanta, GA 30322 USA
[2] Columbia Univ, Coll Mol Recognit, New York, NY 10032 USA
[3] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA
[4] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA
关键词
D O I
10.1074/jbc.275.3.1608
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effect of covalent sulfhydryl modification on dopamine uptake by the human dopamine transporter was determined by rotating disc electrode voltammetry. A transporter construct, X5C, with five mutated cysteines (C90A, C135A, C306A, C319F, and C342A) and the constructs into which the wild-type cysteines were substituted back into X5C, one at a time, all showed nearly normal binding affinity for [H-3]CFT and for cocaine, but they displayed significant reductions in K-m and V-max for DA uptake. Reaction of Cys-90 or Cys-306 with impermeant methanethiosulfonate derivatives enhanced dopamine uptake to a similar extent as the previously observed enhancement of [H-3]CFT binding caused by the same reaction, suggesting that cocaine may bind preferentially to a conformation in the transport cycle. m-Tyramine increased the rate of reaction of (2-amino-ethyl)methanethiosulfonate (MTSEA) with X-A342C, the construct with a cytoplasmic loop residue Cys-342 restored. This m-tyramine-induced increase in reactivity appeared to require the inward transport rather than the outward transport or external binding of m-tyramine, and it was prevented by cocaine. Thus, inward translocation of substrates may involve structural rearrangement of hDAT, which likely exposes Cys-342 to reaction with MTSEA, and Cys-342 may be located on a part of the transporter associated with cytoplasmic gating.
引用
收藏
页码:1608 / 1614
页数:7
相关论文
共 34 条
[1]   NEUROTRANSMITTER TRANSPORTERS - RECENT PROGRESS [J].
AMARA, SG ;
KUHAR, MJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1993, 16 :73-93
[2]  
BONNET JJ, 1990, J PHARMACOL EXP THER, V253, P1206
[3]   CHIMERIC DOPAMINE NOREPINEPHRINE TRANSPORTERS DELINEATE STRUCTURAL DOMAINS INFLUENCING SELECTIVITY FOR CATECHOLAMINES AND 1-METHYL-4-PHENYLPYRIDINIUM [J].
BUCK, KJ ;
AMARA, SG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) :12584-12588
[4]   Effects of serine mutations in transmembrane domain 7 of the human norepinephrine transporter on substrate binding and transport [J].
Burgess, KSD ;
Justice, JB .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) :656-664
[5]   Human norepinephrine transporter kinetics using rotating disk electrode voltammetry [J].
Burnette, WB ;
Bailey, MD ;
Kukoyi, S ;
Blakely, RD ;
Trowbridge, CG ;
Justice, JB .
ANALYTICAL CHEMISTRY, 1996, 68 (17) :2932-2938
[6]   PUTATIVE COCAINE RECEPTOR IN STRIATUM IS A GLYCOPROTEIN WITH ACTIVE THIOL FUNCTION [J].
CAO, CJ ;
YOUNG, MM ;
WONG, JB ;
MAHRAN, LG ;
ELDEFRAWI, ME .
MEMBRANE BIOCHEMISTRY, 1989, 8 (04) :207-220
[7]   External cysteine residues in the serotonin transporter [J].
Chen, JG ;
LiuChen, S ;
Rudnick, G .
BIOCHEMISTRY, 1997, 36 (06) :1479-1486
[8]  
Chen NH, 1999, J PHARMACOL EXP THER, V290, P940
[9]  
Chen NH, 1998, J NEUROSCI, V18, P10257
[10]  
Chen NH, 1998, J NEUROCHEM, V71, P653